Kirkland Advises RLS Radiopharmacies on Sale to Telix
September 24, 2024
September 24, 2024
CHICAGO, Illinois, Sept. 24 -- Kirkland and Ellis, a law firm, issued the following news release:
Kirkland & Ellis counseled RLS Radiopharmacies, America's only Joint Commission-accredited radiopharmacy network, in connection with its agreement to be acquired by Telix Pharmaceuticals Limited (ASX: TLX), a biopharmaceutical company listed on the Australian Securities Exchange.
The acquisition is currently expected to close early in the first quarter of 2025, sub . . .
Kirkland & Ellis counseled RLS Radiopharmacies, America's only Joint Commission-accredited radiopharmacy network, in connection with its agreement to be acquired by Telix Pharmaceuticals Limited (ASX: TLX), a biopharmaceutical company listed on the Australian Securities Exchange.
The acquisition is currently expected to close early in the first quarter of 2025, sub . . .